Treatment of telangiectasias with a 595-nm pulsed dye laser following hemangioma involution: a retrospective analysis.

Publisher: Springer Country of Publication: England NLM ID: 8611515 Publication Model: Electronic Cited Medium: Internet ISSN: 1435-604X (Electronic) Linking ISSN: 02688921 NLM ISO Abbreviation: Lasers Med Sci Subsets: MEDLINE

Publication: London : Springer
Original Publication: London : Baillière Tindall, c1986-

Lasers, Dye*/therapeutic use ; Telangiectasis*/radiotherapy ; Telangiectasis*/surgery ; Hemangioma*/radiotherapy; Humans ; Retrospective Studies ; Female ; Male ; Infant ; Treatment Outcome ; Child, Preschool ; Low-Level Light Therapy/methods

Telangiectasias are the most frequent type of sequelae of infantile hemangiomas after involution. Few studies have reported the treatment of telangiectasias with 595-nm pulsed dye lasers. Therefore, the objective of this study was to assess the efficacy and safety of a 595-nm pulsed dye laser for treating residual telangiectasias following hemangioma involution. This is a retrospective case series that analyzes the medical records and reviews the charts of 22 patients who had undergone 595-nm pulsed dye laser treatment for residual telangiectasias. Pre- and post-treatment digital images were independently assessed, and the changes were scored to ascertain the efficacy of the treatment (0 = no change, 4 = complete improvement). Of the 22 patients, 59.1% experienced complete resolution of telangiectasias following treatment. No serious complications or side effects were reported. The observations indicate that the 595-nm pulsed dye laser is effective and safe for treating residual telangiectasias following hemangioma involution.
(© 2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.)

Rodriguez Bandera AI, Sebaratnam DF, Wargon O et al (2021) Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment[J]. J Am Acad Dermatol, 85(6): pp. 1379–1392. https://doi.org/10.1016/j.jaad.2021.08.019.
Seiffert A, Schneider M, Roessler J et al (2017) Incidence, Treatment Patterns, and Health Care costs of infantile hemangioma: results of a retrospective German database Analysis[J]. Pediatr Dermatol 34(4):450–457. https://doi.org/10.1111/pde.13187. (PMID: 10.1111/pde.1318728675551)
Anderson KR, Schoch JJ, Lohse CM et al (2016) Increasing incidence of infantile hemangiomas (IH) over the past 35 years: correlation with decreasing gestational age at birth and birth weight[J]. J Am Acad Dermatol 74(1):120–126. https://doi.org/10.1016/j.jaad.2015.08.024. (PMID: 10.1016/jjaad20150802426494585)
Chang LC, Haggstrom AN, Drolet BA et al (2008) Growth characteristics of infantile hemangiomas: implications for management[J]. Pediatrics 122(2):360–367. https://doi.org/10.1542/peds.2007-2767. (PMID: 10.1542/peds2007-276718676554)
Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier J et al (2015) A randomized, controlled trial of oral propranolol in infantile hemangioma[J]. N Engl J Med 372(8):735–746. https://doi.org/10.1056/NEJMoa1404710. (PMID: 10.1056/NEJMoa140471025693013)
Baselga E, Roe E, Coulie J et al (2016) Risk factors for degree and type of Sequelae after Involution of untreated hemangiomas of Infancy[J]. JAMA Dermatol 152(11):1239–1243. https://doi.org/10.1001/jamadermatol.2016.2905. (PMID: 10.1001/jamadermatol.2016.290527540637)
Bauland CG, Luning TH, Smit JM et al (2011) Untreated hemangiomas: growth pattern and residual lesions[J]. Plast Reconstr Surg 127(4):1643–1648. https://doi.org/10.1097/PRS.0b013e318208d2ac. (PMID: 10.1097/PRS.0b013e318208d2ac21460670)
Sebaratnam DF, Rodriguez Bandera AL, Wong LF et al (2021) Infantile hemangioma. Part 2: Management[J]. J Am Acad Dermatol 85(6):1395–1404. https://doi.org/10.1016/j.jaad.2021.08.020. (PMID: 10.1016/j.jaad.2021.08.02034419523)
Chang SJ, Yu W, Gu Y et al (2019) Location of infantile hemangioma is a predictor of volumetric sequelae after involution[J]. J Dermatol 46(5):371–375. https://doi.org/10.1111/1346-8138.14847. (PMID: 10.1111/1346-8138.1484730888067)
Lin MY, Lin CS, Hu S et al (2019) The application of 595-nm pulsed dye laser for vascular anomalies in a Chinese population: a 10-year experience[J]. J Cosmet Laser Ther 21(3):171–178. https://doi.org/10.1080/14764172.2018.1502450. (PMID: 10.1080/14764172.2018.150245030052093)
Li D, Chen B, Zhang H et al (2020) Retrospective study of the treatment of port-wine stains with 595-nm pulsed dye laser in 261 Chinese patients[J]. Lasers Med Sci 35(8):1811–1819. https://doi.org/10.1007/s10103-020-03013-2. (PMID: 10.1007/s10103-020-03013-232277405)
Woo SH, Ahn HH, Kim SN et al (2006) Treatment of vascular skin lesions with the variable-pulse 595 nm pulsed dye laser[J]. Dermatol Surg 32(1):41–48. https://doi.org/10.1111/1524-4725.2006.32005. (PMID: 10.1111/1524-4725.2006.3200516393597)
Alam M, Voravutinon N, Warycha M et al (2013) Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: a double-blind randomized controlled trial[J]. J Am Acad Dermatol 69(3):438–443. https://doi.org/10.1016/j.jaad.2013.04.015. (PMID: 10.1016/j.jaad.2013.04.01523688651)
Cerrati EW, O TM, Chung H et al (2015) Diode laser for the treatment of telangiectasias following hemangioma involution[J]. Otolaryngol Head Neck Surg 152(2):239–243. https://doi.org/10.1177/0194599814559192. (PMID: 10.1177/019459981455919225450409)
Chang SJ, Qiao C, Chang L et al (2019) A 7-year follow-up study on untreated deep or mixed facial infantile hemangioma in East-Asian patients: when propranolol was not yet an option[J]. J Dermatol 46(11):962–966. https://doi.org/10.1111/1346-8138.15080. (PMID: 10.1111/1346-8138.1508031515846)
Nakazono M, Kagimoto S, Koike T et al (2022) Clinical outcomes of small infantile hemangiomas treated with pulsed Dye Laser[J]. Dermatol Surg 48(8):833–837. https://doi.org/10.1097/DSS.0000000000003491. (PMID: 10.1097/DSS.000000000000349135580249)
Blei F, Guarini A (2014) Current workup and therapy of infantile hemangiomas[J]. Clin Dermatol 32(4):459–470. https://doi.org/10.1016/j.clindermatol.2014.02.001. (PMID: 10.1016/j.clindermatol.2014.02.00125017457)
Alcantara Gonzalez J, Boixeda P, Truchuelo Diez MT et al (2012) Ablative fractional yttrium-scandium-gallium-garnet laser for scarring residual haemangiomas and scars secondary to their surgical treatment[J]. J Eur Acad Dermatol Venereol 26(4):477–482. https://doi.org/10.1111/j.1468-3083.2011.04103.x. (PMID: 10.1111/j.1468-3083.2011.04103.x21564327)
Scheepers JH, Quaba AA (1995) Does the pulsed tunable dye laser have a role in the management of infantile hemangiomas? Observations based on 3 years’ experience[J]. Plast Reconstr Surg 95(2):305–312. https://doi.org/10.1097/00006534-199502000-00010. (PMID: 10.1097/00006534-199502000-000107824610)
Adamic M, Pavlovic MD, Troilius Rubin A et al (2015) Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology[J]. J Eur Acad Dermatol Venereol 29(9):1661–1678. https://doi.org/10.1111/jdv.13177. (PMID: 10.1111/jdv1317725931003)
Kono T, Sakurai H, Groff WF et al (2006) Comparison study of a traditional pulsed dye laser versus a long-pulsed dye laser in the treatment of early childhood hemangiomas[J]. Lasers Surg Med 38(2):112–115. https://doi.org/10.1002/lsm.20257. (PMID: 10.1002/lsm2025716374781)
Thajudheen CP, Jyothy K, Priyadarshini A (2014) Treatment of port-wine stains with flash lamp pumped pulsed dye laser on Indian skin: a six year study[J]. J Cutan Aesthet Surg 7(1):32–36. https://doi.org/10.4103/0974-2077.129973. (PMID: 10.4103/0974-2077.129973247610973996788)
Khamaysi Z, Pam N, Zaaroura H et al (2023) Nd:YAG 1064-nm laser for residual infantile hemangioma after propranolol treatment[J]. Sci Rep 13(1):7474. https://doi.org/10.1038/s41598-023-33870-0. (PMID: 10.1038/s41598-023-33870-03715681210167233)

No: 21etyy001 The Young and Middle-aged Outstanding Scientific and Technological Talents Training Project of Anhui Provincial Children's Hospital

Date Created: 20240627 Date Completed: 20240627 Latest Revision: 20240627

20240627

10.1007/s10103-024-04113-z

38935161